A Glimpse Into The Expert Outlook On BeiGene Through 4 Analysts
A Glimpse Into The Expert Outlook On BeiGene Through 4 Analysts
通過四位分析師的視角,了解百濟神州的專家展望
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on BeiGene (NASDAQ:BGNE) in the last three months.
在過去三個月中,4位分析師對百濟神州(納斯達克:BGNE)發佈了從看好的到看淡的多樣化評級。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估,下表展示了過去30天內不斷變化的情緒,並將其與之前的幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $270.75, with a high estimate of $300.00 and a low estimate of $235.00. This upward trend is evident, with the current average reflecting a 19.27% increase from the previous average price target of $227.00.
分析師對12個月價格目標的評估提供了額外的見解,展示了平均目標爲270.75美元,最高估計爲300.00美元,最低估計爲235.00美元。這個上升趨勢顯而易見,目前的平均值反映了從之前的227.00美元的平均價格目標上漲了19.27%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The perception of BeiGene by...
金融專家對...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。